Trials / Completed
CompletedNCT00000445
Use of Naltrexone in a Clinical Setting
Effectiveness of Naltrexone in a Community Setting
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This 12-week trial will compare individuals receiving naltrexone or placebo plus substance abuse counseling therapy versus those receiving only substance abuse counseling therapy in a rural, nonacademic setting. A followup period of 12 months is included. The effect on service utilization and the cost of the addition of naltrexone to treatment services for alcohol dependence also will be assessed. The study will expand existing research concerning the effectiveness of naltrexone in clinical trials versus a clinical setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | naltrexone (Revia) |
Timeline
- Completion
- 2002-09-01
- First posted
- 1999-11-03
- Last updated
- 2005-06-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000445. Inclusion in this directory is not an endorsement.